Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Consequences of aneuploidy in human fibroblasts with trisomy 21

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2014723118Source: DataRank Database

Consequences of aneuploidy in human fibroblasts with trisomy 21 is a research paper published in Proceedings of the National Academy of Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 77 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access77 citations

Download PDF

Cite:

Linked data & code

geo gen igsr doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 21.71)OA: greenTopics (69)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Paola Cavaliere,Rui Li ORCID,Lihua Julie Zhu ORCID,Noah Dephoure ORCID,Eduardo M. Torres ORCID

Live enrichment

PubMed:33526671 PMC:PMC8017964 OpenAlex:https://openalex.org/W3127084535

HHS | National Institutes of Health

Grant: 1RO1GM118481

NIGMS NIH HHS

Grant: R01 GM118481

National Institutes of Health

Grant: 1R01GM118481-01A1

Role of de Novo Synthesis of Sphingolipids in Aneuploid Cells

FWCI

21.71

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://www.biorxiv.org/about/FAQ#license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8017964

publisherhttp://www.pnas.org/syndication/doi/10.1073/pnas.2014723118

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2014723118

journalhttps://doi.org/10.1073/pnas.2014723118

Fields of Study

Prenatal Screening and DiagnosticsDown syndrome and intellectual disability researchGenomic variations and chromosomal abnormalities0301 basic medicine03 medical and health sciences0303 health sciencesAneuploidyCell ProliferationCell SurvivalCells, CulturedFibroblastsGene DosageGene Expression ProfilingGene Expression RegulationHumansLipidsMacromolecular SubstancesRNA, MessengerSerineTranscription, GeneticTrisomyUp-Regulation

MeSH Terms

AneuploidyCell SurvivalCells, CulturedFibroblastsGene Expression RegulationHumansLipidsRNA, MessengerSerineTranscription, GeneticTrisomyUp-RegulationGene DosageGene Expression ProfilingMacromolecular SubstancesCell Proliferation

Keywords

AneuploidyTrisomyDown syndromeBiologyChromosome 21ChromosomeGene dosageGeneticsGeneGene expressionDosage compensationTrisomy 21SphingolipidsTranscription, GeneticCell SurvivalMacromolecular SubstancesCongenitalSerineHumansRNA, MessengerCells, CulturedCell ProliferationGene Expression ProfilingCell BiologyBiological SciencesFibroblastsLipidsUp-RegulationHereditaryGene Expression Regulationand Neonatal Diseases and Abnormalities

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being